Search research articles
Contact Us
Filters
Showing results (1-10 of 26) with videos related to
Page
of 3
Sort By:
Heart Rhythm
|
September 11, 2013
Exercise-induced vasovagal syncope
Adam Bőhm, Robert G Kiss, Bela Bachmann, et al.
Cardiology Journal
|
June 28, 2017
Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients
Mate Vamos, Noemi Nyolczas, Zsolt Bari, et al.
The Canadian Journal of Cardiology
|
April 3, 2009
Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy
Bela Merkely, Emese Tóth-Zsamboki, David Becker, et al.
The American Journal of Cardiology
|
February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)
David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Lancet (London, England)
|
September 1, 2009
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
Marc S Sabatine, Elliott M Antman, Petr Widimsky, et al.
Circulation
|
September 5, 2015
Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50
Erin A Bohula, Philip E Aylward, Marc P Bonaca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 2, 2012
Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study
Adam D Tarnoki, David L Tarnoki, Pal Bata, et al.
JACC. Cardiovascular Interventions
|
August 24, 2019
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
Stefan H Hohnloser, Philippe Gabriel Steg, Jonas Oldgren, et al.
JAMA Cardiology
|
September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial
Siddharth M Patel, Robert P Giugliano, David A Morrow, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 21, 2020
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy
Batric Popovic, Emmanuel Sorbets, Jeremie Abtan, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 26) with videos related to
Sort By:
Page
of 3
Heart Rhythm
|
September 11, 2013
Exercise-induced vasovagal syncope
Adam Bőhm, Robert G Kiss, Bela Bachmann, et al.
Cardiology Journal
|
June 28, 2017
Refined heart failure detection algorithm for improved clinical reliability of OptiVol alerts in CRT-D recipients
Mate Vamos, Noemi Nyolczas, Zsolt Bari, et al.
The Canadian Journal of Cardiology
|
April 3, 2009
Very late drug-eluting stent thrombosis after nonsteroidal anti-inflammatory drug treatment despite dual antiplatelet therapy
Bela Merkely, Emese Tóth-Zsamboki, David Becker, et al.
The American Journal of Cardiology
|
February 16, 2016
Outcomes in Stable Patients With Previous Atherothrombotic Events Receiving Vorapaxar Who Experience a New Acute Coronary Event (from TRA2°P-TIMI 50)
David D Berg, Marc P Bonaca, Eugene Braunwald, et al.
Lancet (London, England)
|
September 1, 2009
Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial
Marc S Sabatine, Elliott M Antman, Petr Widimsky, et al.
Circulation
|
September 5, 2015
Efficacy and Safety of Vorapaxar With and Without a Thienopyridine for Secondary Prevention in Patients With Previous Myocardial Infarction and No History of Stroke or Transient Ischemic Attack: Results from TRA 2°P-TIMI 50
Erin A Bohula, Philip E Aylward, Marc P Bonaca, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
June 2, 2012
Heritability of non-alcoholic fatty liver disease and association with abnormal vascular parameters: a twin study
Adam D Tarnoki, David L Tarnoki, Pal Bata, et al.
JACC. Cardiovascular Interventions
|
August 24, 2019
Renal Function and Outcomes With Dabigatran Dual Antithrombotic Therapy in Atrial Fibrillation Patients After PCI
Stefan H Hohnloser, Philippe Gabriel Steg, Jonas Oldgren, et al.
JAMA Cardiology
|
September 1, 2025
Safety of Factor XI Inhibition With Abelacimab in Atrial Fibrillation by Kidney Function: A Prespecified Analysis of the AZALEA-TIMI 71 Randomized Clinical Trial
Siddharth M Patel, Robert P Giugliano, David A Morrow, et al.
European Heart Journal. Acute Cardiovascular Care
|
October 21, 2020
Outcomes in non-ST-segment elevation myocardial infarction patients according to heart failure at admission: Insights from a large trial with systematic early invasive strategy
Batric Popovic, Emmanuel Sorbets, Jeremie Abtan, et al.
Page
of 3